Literature DB >> 26348946

Suicidal thoughts end Amgen's blockbuster aspirations for psoriasis drug.

Charlie Schmidt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26348946     DOI： 10.1038/nbt0915-894b

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  1 in total

1.  The risk of depression, anxiety, and suicidality in patients with psoriasis: a population-based cohort study.

Authors:  Shanu Kohli Kurd; Andrea B Troxel; Paul Crits-Christoph; Joel M Gelfand
Journal:  Arch Dermatol       Date:  2010-08
  1 in total
  7 in total

1.  New anti-IL-23 drugs raise hopes for psoriasis plaque clearance.

Authors:  Elie Dolgin
Journal:  Nat Biotechnol       Date:  2016-12-07       Impact factor: 54.908

2.  Updates on Psoriasis and Cutaneous Oncology: Proceedings from the 2016 MauiDerm Meeting based on presentations by.

Authors:  George Martin; Bruce E Strober; Craig L Leonardi; Joel M Gelfand; Andrew Blauvelt; Arthur Kavanaugh; Linda Stein Gold; Brian Berman; Ted Rosen; Eggert Stockfleth
Journal:  J Clin Aesthet Dermatol       Date:  2016-09-01

Review 3.  Interactions of the Immune System with Skin and Bone Tissue in Psoriatic Arthritis: A Comprehensive Review.

Authors:  Andrea Sukhov; Iannis E Adamopoulos; Emanual Maverakis
Journal:  Clin Rev Allergy Immunol       Date:  2016-08       Impact factor: 8.667

Review 4.  IL-17 and IL-17-producing cells in protection versus pathology.

Authors:  Kingston H G Mills
Journal:  Nat Rev Immunol       Date:  2022-07-05       Impact factor: 108.555

Review 5.  Personalized Antidepressant Selection and Pathway to Novel Treatments: Clinical Utility of Targeting Inflammation.

Authors:  Manish K Jha; Madhukar H Trivedi
Journal:  Int J Mol Sci       Date:  2018-01-12       Impact factor: 5.923

6.  Adverse Events Associated With Anti-IL-23 Agents: Clinical Evidence and Possible Mechanisms.

Authors:  Yi Ru; Xiaojie Ding; Ying Luo; Hongjin Li; Xiaoying Sun; Mi Zhou; Yaqiong Zhou; Le Kuai; Meng Xing; Liu Liu; Yue Luo; Jiankun Song; Jiale Chen; Bin Li; Xin Li
Journal:  Front Immunol       Date:  2021-06-11       Impact factor: 7.561

7.  Efficacy and safety of monoclonal antibodies targeting interleukin-17 pathway for inflammatory arthritis: a meta-analysis of randomized controlled clinical trials.

Authors:  Min Wei; Dongmei Duan
Journal:  Drug Des Devel Ther       Date:  2016-09-09       Impact factor: 4.162
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.